miRNA-574-3p inhibits metastasis and chemoresistance of epithelial ovarian cancer (EOC) by negatively regulating epidermal growth factor receptor (EGFR).

201920 citationsJournal Articlegreen Open Access

Authors

Pengnan Zhang · Obstetrics and Gynecology Hospital of Fudan University

Jie Zhu · Obstetrics and Gynecology Hospital of Fudan University

Ya Zheng · Obstetrics and Gynecology Hospital of Fudan University

Haiyan Zhang · Obstetrics and Gynecology Hospital of Fudan University

Hong Sun · Obstetrics and Gynecology Hospital of Fudan University

Shujun Gao · Obstetrics and Gynecology Hospital of Fudan University

Abstract

Taken together, these data demonstrated that miRNA-574-3p inhibits both tumor metastasis and chemoresistance in EOC via targeting EGFR. Thus, targeting miRNA-574-3p may become a potential molecular method for EOC.

Topics & Keywords

Publication Details

Published in: PubMed

Volume 11, Issue 7, pp. 4151-4165

Field-Weighted Citation Impact: 1.30

Command Palette

miRNA-574-3p inhibits metastasis and chemoresistance of epithelial ovarian cancer (EOC) by negatively regulating epidermal growth factor receptor (EGFR).

Authors

Abstract

Topics & Keywords

Publication Details